More Qu Biologics international research presentations

Dr Hal Gunn, CEO of Qu Biologics, has been invited to present at the US National Cancer Institute (NCI) Conference on Microbial-Based Cancer Therapy. His topic for presentation is “Site-Specific Immunomodulators: Harnessing the Intrinsic Immune Capacity to Prevent and Fight Malignancy”.  Initiated by the NCI Office of Cancer Complementary and Alternative Medicine, the aim of this conference is to present current advances in the field, facilitate new scientific collaborations and interactions, stimulate research and to build new research programs on microbial based therapy. Dr Gunn will present at 1:30 pm on Tuesday July 11th 2017.

Andy Sham, Research Scientist at Qu Biologics, will be presenting new pre-clinical research on QBECO treatment in an animal model of ulcerative colitis at the International Congress of Mucosal Immunology (ICMI) 2017, taking place in Washington D.C. from July 19-22. ICMI is the world’s leading mucosal immunology meeting . He will be presenting at the poster session on Wed July 21st at Poster W45.

Past events:


Past events: